Childrens Triacting Nighttime Liquid
NDC Package 49580-0379-4
Package Information
Childrens Triacting Nighttime (diphenhydramine hcl, phenylephrine hcl) liquids is do not give more than 6 doses in 24 hours unless directed by a doctor. This formulation utilizes a liquid delivery system. Marketed by P & L Development, Llc, this product is identified by NDC 49580-0379 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1236048 - diphenhydrAMINE HCl 6.25 MG / phenylephrine HCl 2.5 MG in 5 mL Oral Solution
- RxCUI: 1236048 - diphenhydramine hydrochloride 1.25 MG/ML / phenylephrine hydrochloride 0.5 MG/ML Oral Solution
- RxCUI: 1236048 - diphenhydramine HCl 12.5 MG / phenylephrine HCl 5 MG per 10 ML Oral Solution
- RxCUI: 1236048 - diphenhydramine HCl 6.25 MG / phenylephrine HCl 2.5 MG per 5 ML Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 49580 - P & L Development, Llc
- 49580-0379 - Childrens Triacting Nighttime
- 49580-0379-4 - 1 BOTTLE, PLASTIC in 1 BOX / 118 mL in 1 BOTTLE, PLASTIC
- 49580-0379 - Childrens Triacting Nighttime
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 49580-0379-4 identifies a specific commercial package of 1 bottle, plastic in 1 box / 118 ml in 1 bottle, plastic of Childrens Triacting Nighttime Cold And Cough Readyincase, a human over the counter drug labeled by P & L Development, Llc. This liquid is formulated for oral use and contains diphenhydramine hydrochloride; phenylephrine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by P & L Development, Llc on November 30, 2014. The current certification is valid through December 31, 2026.
How is this P & L Development, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 49580037904. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.